Small cap MyoKardia up by more than a third on early cardiomyopathy data

Medivation plans a bidding war as it rejects Sanofi’s sweetened bid

As Tesaro jumps 108%, Medivation can raise its price, and even Clovis climbs

Medivation slams Sanofi’s ‘misleading’ claims as merger saga continues

Ex-Stallergenes CEO grabs €8M to advance Sanofi castoff at genitourinary upstart

FDA panel backs 2nd diabetes combo, endorses Sanofi’s iGlarLixi

Langer’s nanoparticle biotech Selecta Biosciences shoots for $75M IPO

FDA frets over the safety of Sanofi’s diabetes combo

Confident Sanofi files pre-merger notification for Medivation

Sanofi teams with Duke, Mass General for data-driven medication adherence project